KETALAR Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ketalar, and when can generic versions of Ketalar launch?
Ketalar is a drug marketed by Endo Operations and is included in one NDA.
The generic ingredient in KETALAR is ketamine hydrochloride. There are eight drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the ketamine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ketalar
A generic version of KETALAR was approved as ketamine hydrochloride by HIKMA on March 22nd, 1996.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for KETALAR?
- What are the global sales for KETALAR?
- What is Average Wholesale Price for KETALAR?
Summary for KETALAR
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 21 |
| Clinical Trials: | 166 |
| Patent Applications: | 4,008 |
| Drug Prices: | Drug price information for KETALAR |
| What excipients (inactive ingredients) are in KETALAR? | KETALAR excipients list |
| DailyMed Link: | KETALAR at DailyMed |
Recent Clinical Trials for KETALAR
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Brian Anderson, MD | Phase 4 |
| Jay Fournier | Phase 1/Phase 2 |
| Stanford University | Phase 2 |
Pharmacology for KETALAR
| Drug Class | General Anesthetic |
| Physiological Effect | General Anesthesia |
US Patents and Regulatory Information for KETALAR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Endo Operations | KETALAR | ketamine hydrochloride | INJECTABLE;INJECTION | 016812-001 | Approved Prior to Jan 1, 1982 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Endo Operations | KETALAR | ketamine hydrochloride | INJECTABLE;INJECTION | 016812-002 | Approved Prior to Jan 1, 1982 | AP | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Endo Operations | KETALAR | ketamine hydrochloride | INJECTABLE;INJECTION | 016812-003 | Approved Prior to Jan 1, 1982 | AP | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
